News
The government has announced the appointment of Professor Susan Hopkins as the new chief executive officer (CEO) of the UK ...
ProteinQure gets US FDA and Health Canada regulatory clearances to begin phase I trial of PQ203 in US and Canada: Toronto Saturday, August 9, 2025, 16:00 Hrs [IST] ProteinQure, a ...
Cosmo Pharma & Takeda renew strategic manufacturing pact for global supply of oral treatment for ulcerative colitis: Dublin, Ireland Saturday, August 9, 2025, 15:00 Hrs [IST] Cosm ...
Dogwood Therapeutics doses first fifty patients in ongoing Halneuron phase 2b CINP clinical trials: Atlanta Saturday, August 9, 2025, 18:00 Hrs [IST] Dogwood Therapeutics Inc, a d ...
Kedrion Biopharma receives US FDA orphan drug designation for plasma-derived treatment for congenital aceruloplasminemia: Forte Lee, New Jersey Saturday, August 9, 2025, 17:00 Hrs ...
Gujarat attracts big ticket investments from Rs. 100 crore to 5,000 crore from MNCs & Indian companies: Shardul Nautiyal, Mumbai Saturday, August 9, 2025, 08:00 Hrs [IST] Gujarat ...
Copenhagen, Denmark Saturday, August 9, 2025, 13:00 Hrs [IST] ...
WHO designates new WHO-Listed Authorities, strengthening global access to quality-assured medical products: Geneva Saturday, August 9, 2025, 09:00 Hrs [IST] The World Health Organ ...
GSK provides update on US settlement of CureVac/BioNTech mRNA patent litigation: London, UK Saturday, August 9, 2025, 10:00 Hrs [IST] GSK plc announces that, in connection with th ...
Boehringer Ingelheim & Click Therapeutics’ phase III CONVOKE study of CT-155 for negative symptoms in schizophrenia meets primary endpoint: Ingelheim, Germany Saturday, August 9 ...
US FDA announces new FDA PreCheck programme to boost US drug manufacturing: Silver Spring, Maryland Saturday, August 9, 2025, 12:00 Hrs [IST] The US Food and Drug Administration a ...
AIOCD vehemently opposes Karnataka govt's proposal to implement third-party inspections of pharmacies: Peethaambaran Kunnathoor, Chennai Saturday, August 9, 2025, 08:00 Hrs [IST] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results